NSF Bets $20 Million on Helping Deep-Tech Startups Cross the Valley of Death

The U.S. National Science Foundation has committed $20 million to a two-year pilot program designed to rescue promising deep-technology ventures from one of the most notorious failure points in American innovation: the so-called “valley of death.” Announced by the agency’s Directorate for Technology, Innovation and Partnerships, the pilot will be led by the University of Central Florida’s newly established National Commercialization and Translation Institute, or NCTI, and will target a specific and stubborn gap in the federal research pipeline. The problem it addresses is well known to entrepreneurs, investors and technology transfer officers alike: a technology can be scientifically validated and substantially de-risked in the laboratory, yet still fail to attract the private capital, business infrastructure and market connections required to become a commercially viable product. By the time many federally funded innovations reach that intermediate stage, the original research grants have expired, but venture investors remain hesitant to commit because the technology has not yet been proven in the marketplace. The result is a funding dead zone in which genuinely transformative ideas, from advanced semiconductors to novel sensing systems, stall indefinitely or die quietly before they ever reach customers.

NSF officials framed the investment as a direct attempt to close that gap and, in doing so, to protect the country’s competitive position in emerging technologies. “NSF invests in small businesses that bring the most innovative cutting-edge technologies to the market and society,” said Erwin Gianchandani, the foundation’s assistant director for Technology, Innovation and Partnerships. “By closing this gap that is known as the ‘valley of death,’ NSF aims to strengthen our commitment to translational research and further develop innovation ecosystems in the United States.” The valley of death, as the agency describes it, is the stage at which a new technological innovation has been substantially de-risked but has not yet been commercially proven, making it difficult to attract the funding or other support needed to achieve commercial viability. For deep-technology companies, whose products often require long development cycles, capital-intensive prototyping and regulatory navigation, that stage can be especially punishing. Unlike software ventures that can iterate quickly and cheaply, hardware-based and science-heavy startups frequently need years of sustained investment before their first meaningful revenue arrives.

The pilot will concentrate its support on companies that have already cleared significant federal hurdles. Its services are aimed at small businesses funded through NSF’s Small Business Innovation Research and Small Business Technology Transfer programs, specifically those that have completed Phase II or Phase IIB awards. These represent the later stages of the federal small-business pipeline, by which point a company has typically demonstrated the technical feasibility of its innovation and begun the hard work of translating it into a manufacturable, sellable product. Lesia Crumpton-Young, the TIP section head for small businesses, emphasized the economic stakes of that translation. “Many NSF-supported small businesses have the potential to become great commercial successes and contribute significantly to economic growth and job creation throughout the nation,” she said. “We want to support small businesses to overcome the hurdles common to commercializing deep technology innovations.” The program’s architects argue that without a deliberate bridge at this late stage, the substantial public investment already made in these companies through earlier SBIR and STTR awards risks being wasted.

At the helm of the new institute is Ivan Garibay, a professor of industrial engineering and management systems at UCF, who will serve as principal investigator. Garibay’s framing of the problem captures the technical distinction at the heart of the pilot’s mission. “A validated technology is a scientific achievement, but it isn’t yet a business,” he said. “Many NSF SBIR Phase II companies hold genuinely de-risked technologies, yet still lack the business expertise, infrastructure, and capital access to turn that validation into a viable company.” His description of NCTI’s role is deliberately complementary rather than duplicative. “NCTI completes that pipeline rather than duplicating any part of it: we coordinate the full continuum of federal resources, managing the handoffs from I-Corps customer discovery through to commercialization support, so each company knows where it stands and what comes next.” That coordination function, in which a single institute orchestrates the various federal programs a startup might otherwise have to navigate alone, is one of the pilot’s most distinctive design features.

The support package offered to participating companies is structured as what the program calls concierge-level individualized assistance. Each selected business will undergo a diagnostic triage to identify its specific commercialization bottlenecks, followed by the creation of an individualized commercialization plan tailored to its technology, market and funding situation. Companies will be paired with dedicated mentor teams and will receive curated introductions to potential customers, investors, industry partners and national laboratories, the latter offering access to specialized facilities and technical expertise that small startups could rarely afford on their own. Alongside this individualized support, the institute will provide direct commercialization funding, expert mentorship and connections to investors. The intent is to address simultaneously the three deficits that Garibay identified as the core of the valley of death: business expertise, infrastructure and access to capital. Peter Atherton, program director for NSF Small Business Innovation Research and Small Business Technology Transfer, described the approach as a bridge. “Providing a ‘bridge’ to support our late-stage NSF-funded companies will move their impactful innovation to the market more quickly and thereby benefit the national economy,” he said.

NCTI is not a sudden departure for UCF but rather the latest evolution of a commercialization pipeline the university has spent years constructing. Through initiatives including the Southeast Hub of NSF I-Corps, which trains researchers in customer discovery and lean startup methodology; NSF’s Accelerating Research Translation program, which builds institutional capacity to move academic discoveries toward practical use; and the Florida Semiconductor Engine, a regional coalition advancing the semiconductor industry, UCF has already helped researchers evaluate commercial opportunities, advance emerging technologies and strengthen regional innovation ecosystems. NCTI will build on that foundation while dramatically expanding its scope, extending UCF’s commercialization machinery to companies nationwide rather than confining it to Florida and the Southeast. University leadership has positioned the institute as a natural outgrowth of that trajectory. “NCTI builds on UCF’s growing national leadership in helping promising technologies become products, companies and economic growth,” said UCF President Alexander N. Cartwright, who added that Central Florida’s concentration of talent, industry and innovation positions the university to build a model with impact across the nation.

University research officials argue that the institute’s success will depend on the integration of the entrepreneurial infrastructure already in place at UCF. Winston Schoenfeld, the university’s vice president for research and innovation, described that integration as the anchor of the institution’s readiness. “UCF’s readiness to lead this national effort is anchored by our highly integrated entrepreneurial infrastructure critical in the ‘lab-to-market’ pipeline,” he said. “NCTI will ensure that federally funded technologies successfully transition into investor-ready commercial enterprises.” The phrase “investor-ready” is significant, because it identifies the precise handoff point where the valley of death typically opens. A company becomes investor-ready when its technology has been validated, its market has been defined, its team has been strengthened and its path to revenue is credible enough to attract private capital. Reaching that state requires exactly the combination of funding, mentorship and networking that the pilot intends to supply, and it is the state at which federal support has historically ended and private investment has historically been slow to begin.

Beyond its immediate services to individual companies, the pilot carries a broader experimental mandate: it is explicitly designed as a test of whether a scalable, long-term national model is feasible. Each stage of the program will be structured and independently evaluated, with the results determining whether NSF establishes a permanent program on the pilot’s foundation. That evaluative rigor reflects a growing recognition across the federal science establishment that commercialization outcomes can and should be measured as carefully as research outcomes. The factors, conditions and approaches that lead to the successful transition of deep-technology innovations into nationally impactful technologies will be systematically examined, generating evidence about which interventions, whether diagnostic triage, mentor teams, investor introductions or direct funding, actually move companies across the valley. If the pilot demonstrates measurable success, it could reshape how federal agencies support the late-stage development of science-based startups for years to come.

The stakes of the experiment extend well beyond the companies that participate. Deep technologies, which include advanced materials, quantum systems, biotechnology platforms, next-generation semiconductors and other science-intensive innovations, are widely viewed as critical to both economic competitiveness and national security, and competitors abroad have invested heavily in smoothing their own translation pipelines. When American startups fail in the valley of death, the underlying research, often funded by taxpayers through agencies like NSF, may be licensed abroad, shelved indefinitely or lost entirely, along with the jobs and industries it could have created. By intervening at the precise moment when public funding ends and private capital has not yet arrived, the NCTI pilot represents a deliberate attempt to keep that value inside the American innovation ecosystem. Whether a $20 million, two-year investment can meaningfully change the survival rates of deep-technology ventures remains to be seen, but the program’s designers are betting that coordinated, individualized, late-stage support can convert more laboratory-validated science into products, companies and economic growth, and that the lessons learned will justify a permanent national commitment.

Subject of Research: A $20 million NSF pilot program led by the University of Central Florida to help small businesses commercialize late-stage deep technologies and avoid the valley of death.

Article Title: NSF funds pilot program to support small businesses in accelerating commercialization of their late-stage deep-technology and avoid the “valley of death”

Article References: NSF funds pilot program to support small businesses in accelerating commercialization of their late-stage deep-technology and avoid the “valley of death”. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: NSF, valley of death, deep technology, commercialization, SBIR, STTR, University of Central Florida, NCTI, small business, technology transfer, innovation ecosystem, startup funding